The current results indicated that the iNTR is a novel, independent prognostic factor for a high rate of disease recurrence and poor OS in patients with resectable NSCLC.
2012-03-05
Eng.
Cancer
Laboratory of Clinical and Experimental Pathology, Louis Pasteur Hospital, University Hospital Center of Nice, Nice, France.
Cancer. 2012 Mar;118(6):1726-37
© Galenicom 1999-2013